Both in Pharmaceuticals
BridgeBio Oncology Therapeutics vs Akebia Therapeutics
Over the past year BBOT returned −78.2% and AKBA returned −66.4%; their daily moves had a correlation of 0.21.
BBOT −78.2% AKBA −66.4%Growth of $1, one year, split-adjusted
| Metric | BBOT | AKBA |
|---|---|---|
| Price | $2.62 | $0.7065 |
| Market cap | $210.1M | $195.8M |
| Today | −2.96% | −4.81% |
| 1 month | −33.5% | −18.9% |
| 6 months | −68.8% | −49.5% |
| Year to date | −79.1% | −56.1% |
| 1 year | −77.4% | −66.4% |
| Revenue growth (YoY) | — | −21.4% |
| Gross margin | — | 78.8% |
| Net margin | — | −18.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $225.7M | $106.0M |
| Dividend yield | — | — |
| Volatility (60d) | 86.9% | 73.8% |
| Short % of float | 13.9% | 8.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).